Explore more publications!
Healthcare Wire Hong Kong
Got News to Share?

Healthcare Wire Hong Kong: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Hong Kong.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 13, 2026

Southern Pain and Spine Specialists Announces Dr. Ammar Alamarie, MD Named Castle Connolly Top Doctor for Pain Management in 2025 for Second Consecutive Year
January 13, 2026

Southern Pain and Spine Specialists Announces Dr. Ammar Alamarie, MD Named Castle Connolly Top Doctor for Pain Management in 2025 for Second Consecutive Year

Indeterminate GlobeNewswire
OC WASTE & RECYCLING PARTNERS WITH AGROMIN TO EXPAND COMPOST AND MULCH PROGRAM
January 13, 2026

OC WASTE & RECYCLING PARTNERS WITH AGROMIN TO EXPAND COMPOST AND MULCH PROGRAM

Indeterminate GlobeNewswire
The Ebony Canal Scores NAACP Image Award Nomination for Outstanding Short Form Documentary
January 13, 2026

The Ebony Canal Scores NAACP Image Award Nomination for Outstanding Short Form Documentary

Indeterminate GlobeNewswire
Metabo Drops Examined: Is It Legit for Weight Loss? Safety Checks and Consumer Analysis 2026
January 13, 2026

Metabo Drops Examined: Is It Legit for Weight Loss? Safety Checks and Consumer Analysis 2026

Indeterminate GlobeNewswire
La FDA américaine accorde la désignation « Breakthrough Therapy » à l’IPN60340 (ICT01) d’Ipsen dans la leucémie myéloïde aiguë de première ligne chez les patients inéligibles à une chimiothérapie intensive
January 13, 2026

La FDA américaine accorde la désignation « Breakthrough Therapy » à l’IPN60340 (ICT01) d’Ipsen dans la leucémie myéloïde aiguë de première ligne chez les patients inéligibles à une chimiothérapie intensive

Indeterminate GlobeNewswire
U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia
January 13, 2026

U.S. FDA grants Ipsen’s IPN60340 (ICT01) Breakthrough Therapy Designation in first line unfit Acute Myeloid Leukemia

Indeterminate GlobeNewswire
Blue Cross and Blue Shield of Minnesota Adds Virtual Primary Care from Doctor On Demand to Provider Network
January 13, 2026

Blue Cross and Blue Shield of Minnesota Adds Virtual Primary Care from Doctor On Demand to Provider Network

Indeterminate GlobeNewswire
Allsup Veterans Appeals Urges Veterans to Take Action on Denied and Underrated VA Claims Before Appeal Deadline Closes
January 13, 2026

Allsup Veterans Appeals Urges Veterans to Take Action on Denied and Underrated VA Claims Before Appeal Deadline Closes

Indeterminate GlobeNewswire
Synfini Assessed ‘Awardable’ for DARPA ERIS Marketplace
January 13, 2026

Synfini Assessed ‘Awardable’ for DARPA ERIS Marketplace

Indeterminate GlobeNewswire
Evaluation Finds Significant Quality Improvements in Independent Practices Across Los Angeles
January 13, 2026

Evaluation Finds Significant Quality Improvements in Independent Practices Across Los Angeles

Indeterminate GlobeNewswire
American Case Management Association Opens Registration for the 2026 National Conference
January 13, 2026

American Case Management Association Opens Registration for the 2026 National Conference

Indeterminate GlobeNewswire
NASM Data Reveals the End of the "Before & After" Photo: Longevity Overtakes Aesthetics as Top Fitness Goal
January 13, 2026

NASM Data Reveals the End of the "Before & After" Photo: Longevity Overtakes Aesthetics as Top Fitness Goal

Indeterminate GlobeNewswire
WOWorks Defines Better-for-You Dining in 2026 with Protein-Rich, Customizable Menus
January 13, 2026

WOWorks Defines Better-for-You Dining in 2026 with Protein-Rich, Customizable Menus

Indeterminate GlobeNewswire
Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform
January 13, 2026

Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform

Indeterminate GlobeNewswire
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
January 13, 2026

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

Indeterminate GlobeNewswire
Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain
January 13, 2026

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

Indeterminate GlobeNewswire
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery
January 13, 2026

Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery

Indeterminate GlobeNewswire
Conavi Medical Corp. Announces Closing of $12M Public Offering
January 13, 2026

Conavi Medical Corp. Announces Closing of $12M Public Offering

Indeterminate GlobeNewswire
Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging
January 13, 2026

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Indeterminate GlobeNewswire
Nu-Tek BioSciences stärkt seine globale Marktführerschaft durch Erneuerung der Halal-Zertifizierung
January 13, 2026

Nu-Tek BioSciences stärkt seine globale Marktführerschaft durch Erneuerung der Halal-Zertifizierung

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions